The Health Resources and Services Administration said it stands by its interpretation of the Affordable Care Act orphan drug exclusion, despite a recent court ruling that challenged its authority to engage in legislative rulemaking.
Federal prosecutors earlier this week filed a complaint against the Memphis Methodist health system, taking over a qui tam action initially filed by private whistleblowers, who alleged that Methodist’s six-year arrangement with West Clinic, an oncology private practice, violated the Anti-Kickback Statute and the False Claims Act.
